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Abstract A subset of Escherichia coli proteins, in particular
cofactor-binding proteins with so-called twin-arginine signal
peptides, is transported to the periplasm via the twin-arginine
translocation (Tat) pathway. The tatA and tatB genes encode
important components of the export system and we have analysed
whether the proteins encoded by these genes physically interact.
Using co-immunoprecipitation experiments, we show that TatA
and TatB do indeed associate with each other. Gel filtration
chromatography demonstrates that both proteins are present in a
large complex with an apparent molecular mass of approxi-
mately 600 kDa, indicating the presence of other components
and/or several TatA and TatB subunits. Finally, we show that
TatA is stable in the absence of TatB and may participate in a
separate complex lacking TatB in wild-type cells.
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1. Introduction
In prokaryotes, most proteins that are translocated across
the cytoplasmic membrane utilise the Sec machinery [1,2]. The
translocase involved comprises a membrane-bound complex,
consisting minimally of SecY, SecE, and SecG, and the pe-
ripheral membrane protein SecA that functions as the trans-
location motor. Translocation through this membrane com-
plex is by a threading mechanism that excludes proteins with
signi¢cant tertiary structure.
Recently, a novel translocation pathway was discovered in
bacteria [3^5], and termed the twin-arginine translocation
(Tat) pathway. This pathway is structurally related to the
thylakoidal vpH pathway [6]. A characteristic feature of sub-
strates transported by the Tat pathway is that they contain
unusually long signal peptides with a conserved twin-arginine
motif directly upstream of the hydrophobic domain, with a
consensus sequence S/TRRxFLK [7]. In prokaryotes, most
proteins with twin-arginine signal peptides bind complex re-
dox cofactors, such as iron^sulfur clusters or molybdopterin
cofactors [7]. These cofactors are believed to be inserted in the
cytoplasm, which would require proper folding before trans-
location. Therefore, it is likely that cofactor-containing pro-
teins with a twin-arginine signal peptide are translocated in a
folded state [6,7].
In Escherichia coli, four genes encoding Tat components
have thus far been identi¢ed. These are the tatA, tatB, and
tatC genes, which are located in one operon, and the unlinked
tatE gene [3^5]. The tatA, tatB, and tatE genes are homo-
logues of the hcf106 and tha4 genes from maize, which were
shown to be components of the thylakoidal vpH-dependent
translocation system [8^10]. Recently, it was shown that TatA
and TatE are functionally interchangeable, whereas TatB is
functionally distinct [11]. The TatA, TatB, and TatE proteins
are predicted to be type I membrane proteins, with a single
membrane-spanning helix at the amino-terminus followed by
a cytoplasmic domain. TatC is predicted to be an integral
membrane protein containing six membrane-spanning do-
mains with the amino- and carboxyl-termini in the cytoplasm.
Although the tatABCE gene products are clearly involved
in Sec-independent protein export in E. coli, little is known
about the composition of the Tat translocase or the roles of
TatA, TatB, TatC, and TatE. Thus far, it has only been
shown that TatC is rapidly degraded in the absence of TatB
[11], suggesting that TatB forms a complex with TatC. The
composition of the corresponding thylakoidal vpH-dependent
translocase is similarly obscure at present, although there is
evidence for the presence of a large complex during the trans-
location process. In pea thylakoids, a chimeric precursor pro-
tein (denoted ‘16/23’) was found to be arrested within the
membrane during translocation [12], and the translocation
intermediates were found in two distinct complexes with ap-
parent molecular masses of 560 and 620 kDa, respectively.
These data suggested the presence of a large translocase in
which these intermediates were trapped.
In the present study, we have sought to analyse subunit
interactions in the Tat translocase, focusing on the two major
Hcf106 homologues of E. coli, TatA and TatB. We show that
these proteins physically interact with each other and that
both proteins are present in a large complex of approximately
600 kDa. Our data furthermore indicate that TatB is largely
unstable in the absence of TatA. In contrast, TatA is stable in
mutants lacking either TatB or TatC, and can be detected as a
separate pool in large complexes lacking TatB.
2. Materials and methods
2.1. Bacterial strains, plasmids and growth conditions
E. coli strain MC4100 (F-vlacU169 araD139 rpsL150 relA1 ptsF rbs
£bB5301) [13] was the parental strain. ELV15 (MC4100 vtatA),
JARV15 (MC4100 vtatAE), B0D (MC4100 vtatB), and B1LK0
(MC4100 vtatC) have been described before [4,5,11]. Arabinose is
toxic for MC4100 and its derivatives, due to the presence of the
araD139 mutation [14]. To be able to use the pBAD vectors [15],
which contain an arabinose-inducible promoter, strains that were re-
sistant to arabinose, but unable to use arabinose as carbon source,
were isolated from MC4100 and its derivatives as described [14]. E.
coli was grown aerobically in TY medium, containing tryptone (1%),
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yeast extract (0.5%) and NaCl (1%), or anaerobically in M9 minimal
salts [16] supplemented with glycerol (0.5%), TMAO (0.4%), CaCl2
(0.1 mM), MgSO4 (2 mM), thiamine (0.001%), (NH4)6Mo7O24W4H2O
(1 WM), and K2O3Se (1 WM). Ampicillin was used at 100 Wg/ml.
To construct TatA with a hexahistidine-tag at the carboxyl-termi-
nus, a DNA fragment containing the tatA gene was ampli¢ed with the
primers AB.tatA1 (ataccATGGGTGGTATCAGTATTTG; nucleoti-
des identical to genomic template DNA are printed in capital letters
and restriction sites used for cloning are underlined) and AB.tatA3
(ataaagcttagtgatggtgatggtgatgCACCTGCTCTTTATCGTGG; the se-
quence specifying the hexahistidine-tag is indicated in bold) using
MC4100 chromosomal DNA as template. The resulting product was
digested with NcoI and HindIII and cloned into plasmid pBAD24,
resulting in plasmid pBAD-tatAhis. The gene encoding TatBhis was
cloned in a similar way, using the primers AB.tatB1 (ataccatgG-
TGTTTGATATCGGTTTTAG) and AB.tatB3 (ataaagcttagtgatggt-
gatggtgatgCGGTTTATCACTCGACGAAG). The resulting plasmid
was denoted pBAD-tatBhis. As the tatB gene starts with a GTG start
codon, an additional ATG start codon was introduced to enable li-
gation into the NcoI restriction site of pBAD24.
2.2. Antibodies
The tatABC operon was cloned into the vector pFAT75 and over-
expressed in E. coli ; the membrane fraction was then solubilised and
subjected to gel ¢ltration. The TatA and TatB proteins elute in the
high molecular mass fraction (F. Sargent, B.C Berks and T. Palmer,
manuscript in preparation). These samples were run on SDS^polyac-
rylamide gels and the TatA and TatB bands were electro-eluted; anti-
bodies to TatA and TatB were then raised in rabbits. Antibodies to
TatB were puri¢ed by the methods described [17], using TatB coupled
to CNBr-activated Sepharose 4B (Amersham Pharmacia Biotech).
2.3. SDS^PAGE and Western blot analysis
Proteins were separated by SDS^PAGE, as previously described
[18]. Western blotting was performed using a semi-dry system as de-
scribed by Kyhse-Andersen [19]. After separation by SDS^PAGE,
proteins were transferred to polyvinylidene di£uoride membranes
(Roche Molecular Biochemicals). Proteins were visualised with specif-
ic antibodies and horseradish peroxidase anti-rabbit IgG conjugates,
using the ECL detection system of Amersham.
2.4. Isolation of membranes and immunoprecipitation
Cells were grown to a mid-exponential growth phase. Cells were
collected by centrifugation and sphaeroplasted as described [20].
Sphaeroplasts were collected by centrifugation, resuspended in bu¡er
A (50 mM Tris^HCl pH 8.0, 20% glycerol, 100 mM KCl), and dis-
rupted by sonication. Intact cells and cellular debris were removed by
centrifugation (5 min at 10 000Ug). Membranes were separated from
the cytoplasmic contents by centrifugation (30 min at 250 000Ug,
4‡C). Membranes were resuspended in bu¡er B (50 mM Tris^HCl
pH 8.0, 200 mM KCl, 10% glycerol) at a ¢nal concentration of 0.5
mg/ml protein and solubilised by the addition of 1% (v/v) digitonin.
Insoluble material was removed by centrifugation (15 min at
250 000Ug). Proteins were incubated with anti-TatA or anti-TatB
serum for 3 h at 4‡C. For control immunoprecipitations, an equal
amount of irrelevant antiserum (raised against spinach photosystem
II subunit W) was included. Next, 10 mg of protein A Sepharose was
added, and the samples were incubated for an additional 2 h. Immu-
noprecipitates were isolated by centrifugation, washed four times with
bu¡er B containing 0.5% digitonin, and resuspended in SDS sample
bu¡er. Immunoprecipitated proteins were visualised by SDS^PAGE
and Western blotting. His-tagged proteins were speci¢cally visualised
using an antiserum to the hexahistidine-tag (Invitrogen).
3. Results and discussion
3.1. TatB levels are a¡ected in cells lacking TatA
The subunit composition of the translocase involved in the
Tat pathway has not been addressed in previous studies, and
we investigated this issue using wild-type cells or cells express-
ing the Tat components at levels comparable to that of wild-
type cells. To facilitate the detection of TatA or TatB in wild-
type cells, antibodies were raised against these proteins as
detailed in Section 2. Fig. 1, upper panel shows that the
TatA antiserum recognises an 18 kDa protein in wild-type
cells and that this protein is absent in extracts of the mutant
strain lacking the tatA gene (lane vA). The antiserum also
reacts with a lower molecular mass protein, denoted by an
asterisk; this may well be due to non-speci¢c interactions,
although this remains to be con¢rmed. The TatB antiserum
recognises a single 30 kDa protein in wild-type cells that is
absent in the vtatB mutant (lane vB).
In order to achieve plasmid-borne expression at wild-type
levels, genes encoding hexahistidine-tagged TatA (TatAHis) or
TatB (TatBHis) were cloned into the vector pBAD24 [15]. This
vector contains the arabinose-inducible PBAD promoter, the
activity of which can be modulated by varying the concentra-
tion of arabinose. To test whether TatAHis and TatBHis were
functional proteins, pBAD-tatAhis and pBAD-tatBhis were
transformed to the vtatAE and vtatB mutant strains, respec-
tively. The latter two strains are unable to grow anaerobically
in minimal medium containing glycerol as the carbon source
and trimethylamine N-oxide (TMAO) as the ¢nal electron
acceptor [3,4], as TMAO reductase is dependent on the Tat
pathway for its export to the periplasm. Both TatAHis and
TatBHis were able to restore the growth defect, showing that
the His-tagged derivatives are functional proteins (data not
shown). As expected, TatAHis and TatBHis showed a slightly
reduced mobility in SDS^PAGE gels compared to the pro-
teins without the His-tags (Fig. 1, upper and lower panel).
The presence of arabinose at even low concentrations (be-
tween 0 and 2 WM) results in expression of TatAHis in vtatA
(pBAD-tatAhis) cells at levels comparable with those of TatA
in wild-type cells. In contrast, wild-type TatB levels were sig-
ni¢cantly below that of vtatB (pBAD-tatBhis) cells without
arabinose induction. TatAHis or TatBHis were not absent in
Fig. 1. Detection of TatA and TatB. Cells of E. coli MC4100 (WT),
vtatA (vA), vtatB (vB), all containing pBAD24 (vector without in-
sert), were grown in TY medium until the end of the exponential
growth phase. Cells were collected by centrifugation, and TatA or
TatAHis was visualised by SDS^PAGE and Western blotting. Simi-
larly, cells of E. coli vtatA containing pBAD-tatAhis (vector con-
taining tatAhis gene), or vtatB containing pBAD-tatBhis (vector
containing tatBhis gene) were grown in the presence of 0 or 2 WM
arabinose (lanes indicated as 0 and 2) in TY medium, and analysed
by Western blotting using antisera raised against TatA (upper pan-
el) or TatB (lower panel). Mobilities of molecular mass markers (in
kDa) are indicated.
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cells grown without arabinose, due to a low basal level of
expression from the PBAD promoter.
To test whether the levels of TatA or TatB were a¡ected in
the strains lacking known tat genes, Western blotting experi-
ments were carried out using wild-type cells and cells lacking
functional tatA, tatB, tatC, or tatE genes. As shown in Fig. 2,
upper panel, the level of TatA was not a¡ected in tatB, tatC,
or tatE mutant strains, indicating that this protein is stable in
the absence of a functional Tat translocase. However, TatB
was present in much-reduced amounts in the vtatA strain and
vtatAE strains, but not in the tatC or tatE mutant strains
(Fig. 2, lower panel). This strongly suggests that TatB is un-
stable in the absence of TatA. An alternative possibility is that
tatB expression is reduced in cells lacking TatA, but it is
improbable to have polar e¡ects a¡ecting expression, since
the vtatA mutant strain contains an in-frame deletion of the
tatA gene. Thus, it is likely that TatB interacts, either directly
or indirectly, with TatA and is unstable in its absence. The
level of TatA does not depend on the presence of TatB, show-
ing that TatA is not prone to degradation in the absence of
TatB. Our results are contradicted by recent observations of
Sargent et al. [11], who did not see an e¡ect on the stability of
TatB in a strain lacking TatA. However, it has to be noted
that in this paper the experiments di¡ered on two major
points. Firstly, Sargent et al. analysed TatB levels in a strain
overexpressing the entire tatABCD operon on a plasmid, and
secondly, they used pulse-chase experiments to analyse the
stability of the various proteins. In contrast, in our experi-
ments the wild-type level of proteins was analysed in steady-
state conditions. As under these conditions TatB was still
present in low amounts in a vtatA strain, it can be anticipated
that the kinetics of TatB degradation are rather slow, and not
detectable by pulse-chase analysis.
3.2. TatA interacts with TatB
To test more directly for an interaction between TatA and
TatB, co-immunoprecipitation experiments were performed
under native conditions. Membranes were isolated from E.
coli MC4100, and the vtatA and vtatB strains, solubilised
with digitonin, and immunoprecipitated with anti-TatA or
anti-TatB. As shown in Fig. 3A, TatA could be e¡ectively
immunoprecipitated from wild-type or vtatB cells (lanes
WT, vB) using antibodies raised against TatA (‘IP K-TatA’
panel). The lower molecular mass contaminating protein, ob-
served in the Western blots in Fig. 1, is also immunoprecipi-
tated by these antibodies (asterisk). This protein is also im-
munoprecipitated from vtatA cells, but the TatA protein is
absent as expected. Signi¢cantly, TatA is also immunopreci-
pitated from wild-type cells by the TatB antiserum (panel ‘IP
K-TatB’). No co-immunoprecipitation of TatA is observed
from vtatA cells (con¢rming that the protein detected on
the blot is indeed TatA) or from strains lacking TatB. The
latter result con¢rms that the anti-TatB antiserum does not
recognise the native TatA protein, and TatA must therefore
be immunoprecipitated by virtue of its interaction with TatB.
No immunoprecipitation of either TatA or the lower molec-
ular mass protein is observed in control experiments using an
irrelevant antiserum raised against a thylakoid membrane pro-
tein (‘IP control’ panel). These data demonstrate that the two
proteins are present within a single complex. In this and other
experiments, we have found that approximately 5% of the
TatA can be immunoprecipitated using the TatB antiserum.
This might re£ect the di⁄culty in immunoprecipitating the
entire TatB population but we believe that a more likely ex-
planation is that only a relatively small proportion of TatA is
actually in a complex with TatB (see below).
Parallel tests using the anti-TatA serum demonstrated co-
immunoprecipitation of TatB together with TatA, but a high
Fig. 2. TatA and TatB levels in tat-de¢cient strains. Cells of E. coli
MC4100, vtatA, vtatB, vtatC, vtatE, or vtatAE were grown in TY
medium until the end of the exponential growth phase. Cells were
collected by centrifugation and TatA or TatB were visualised by
SDS^PAGE and Western blotting as in Fig. 1. Equal amounts of
cells were loaded in each lane (standardised on the basis of optical
density).
Fig. 3. Co-immunoprecipitation of TatA with TatB. A: Membranes
of E. coli MC4100 (WT), vtatA (vA), or vtatB (vB) were solubi-
lised with digitonin, and immunoprecipitation was performed using
anti-TatA or anti-TatB antibodies (IP K-TatA or K-TatB, respec-
tively) or with an antiserum raised against PsbW, a thylakoid mem-
brane protein (IP control). TatA was visualised by SDS^PAGE and
Western blotted using the antiserum to TatA. B: Membranes of E.
coli vtatA containing pBAD-tatAhis (vA/AHis), or vtatB containing
pBAD-tatBhis (vB/BHis) were solubilised with digitonin and immu-
noprecipitation was performed using anti-TatA antibodies. TatA
and TatB were visualised by SDS^PAGE and Western blotting, us-
ing monoclonal antibodies recognising the hexahistidine-tag (‘detect
K-His’). His-tagged proteins were expressed using an arabinose con-
centration of 1 WM in each case.
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level of background reaction was observed, apparently with
the IgG proteins that migrate in the TatB region of the gel
(data not shown). This problem was circumvented by express-
ing plasmid-encoded, His-tagged TatB (TatBHis ; see Fig. 1) in
the vtatB strain lacking chromosome-encoded TatB. In these
experiments, TatB was detected using antibodies that speci¢-
cally recognise the His-tag; these antibodies were found to
generate much lower background reactions in Western blots
of immunoprecipitates (data not shown). For control pur-
poses, His-tagged TatA (TatAHis) was also expressed in vtatA
strains. Fig. 3B shows the results obtained when cell extracts
were immunoprecipitated with TatA antibodies and then
Western blotted with the His-tag antibodies (to detect TatAHis
or TatBHis in the immunoprecipitates). The data con¢rm that
TatAHis is immunoprecipitated from vtatA cells expressing
TatAHis (lane vA/AHis). Importantly, the adjacent lane (vB/
BHis) shows a clear TatBHis signal, demonstrating that this
protein was co-immunoprecipitated using anti-TatA antibod-
ies and providing further evidence that TatA and TatB are
located within the same complex. Neither TatA nor TatB are
immunoprecipitated by control antibodies.
3.3. TatA and TatB are subunits of a complex with a molecular
mass of 600 kDa
Attempts to isolate a complex containing TatA and TatB
using His-tagged proteins were not successful, as the complex
appeared to be unstable during nickel a⁄nity chromatogra-
phy. Therefore, gel ¢ltration chromatography was used to
investigate the complex in which TatA and TatB participate
in more detail. To this purpose, E. coli MC4100 membranes
were solubilised using Nonidet P-40 and the extracted proteins
were separated on a Superose 6HR column. The amounts of
TatA and TatB in the various fractions were determined by
Western blotting. Fig. 4 shows that TatB elutes in a single
Fig. 4. TatA and TatB participate in a complex of ca. 600 kDa. E. coli MC4100 membranes were solubilised in a bu¡er containing 50 mM
Tris^HCl pH 8.0, 200 mM KCl, 10% glycerol, and 1% Nonidet P-40. Solubilised proteins (250 Wl ; corresponding to 5 ml culture with an
OD600 of 0.7) were fractionated on a Superose 6HR column (Amersham Pharmacia Biotech). Elution was with a bu¡er 50 mM Tris^HCl pH
8.0, 200 mM KCl, 10% glycerol, and 0.1% Nonidet P-40, at a £ow rate of 0.2 ml/min. Fractions of 0.6 ml were collected, and protein elution
was monitored by absorbance (A) at 280 nm. Fractions were precipitated with 10% trichloroacetic acid, and TatA or TatB were detected by
Western blot analysis; fractions containing TatA or TatB are shown in the inset. The column was calibrated with the following proteins: thyro-
globulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), aldolase (158 kDa), and lysozyme (14.4 kDa). MW, molecular weight; Vo, void vol-
ume.
Fig. 5. Ion-exchange chromatography of TatA and TatB. Fractions
19^21 from the Superose eluate shown in Fig. 4 were pooled, di-
luted in an equal volume of 50 mM Tris^HCl, pH 8.0, 10% glycer-
ol, 0.1% (v/v) Nonidet P-40 and loaded on a 1 ml mono-Q column
equilibrated in the same bu¡er containing 100 mM KCl. Samples
were collected of the £ow-through (lane F) and fractions eluted dur-
ing washing of the column (lane W) with 5 ml of the above bu¡er
containing 100 mM KCl. Elution was then performed using a KCl
gradient of 100^400 mM (lanes 1^8). Samples of each fraction were
Western blotted using antisera to TatA and TatB as indicated.
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peak corresponding to a molecular mass of approximately 600
kDa. TatA also elutes in a single peak and, given the co-
immunoprecipitation data, at least some of the TatA mole-
cules must be bound to TatB. The observed size of this com-
plex is very similar to that of the putative thylakoid Tat com-
plex [12]. However, in this and other experiments we have
found that the TatA and TatB elution peaks di¡er, with
TatA elution consistently observed to elute in a wider range
of fractions. This observation strongly suggests that either the
TatA:TatB ratio varies considerably in Tat complexes, or that
some TatA molecules are in the form of a di¡erent high mo-
lecular mass complex that possibly does not contain TatB. In
either case, the size of the TatB/TatA-containing complex
suggests the presence of other subunits and/or the presence
of several copies of TatA, TatB or TatC. No TatA or TatB
was detected in other column fractions corresponding to the
lower molecular mass proteins (not shown), strongly suggest-
ing that under these conditions most or all of the TatA and
TatB is present in large complexes.
The fractionation characteristics of TatA and TatB were
further analysed by subjecting the Superose eluate to ion-ex-
change chromatography. Fig. 5 shows that the elution of the
two proteins di¡ers signi¢cantly. TatB elutes as a sharp peak
at KCl concentrations of approximately 250 mM (fractions 4
and 5). In contrast, TatA is detected in the £ow-through and
wash fractions (lanes F, W) as well as in most of the salt
gradient fractions. However, it is notable that TatA elution
peaks in fractions 4 and 5, which is consistent with this pop-
ulation of the molecules being in a complex together with
TatB. Although we can not exclude the possibility that
TatA is removed from the Tat complex during fractionation,
we believe that these data, together with those shown in Fig.
4, support the proposal that TatB is almost entirely in the
form of a large complex whereas TatA is present as two dis-
tinct populations, one of which is complexed with TatB (and
presumably other Tat components) whereas the other is in a
separate complex lacking TatB.
3.4. Implications for the Tat translocase
In conclusion, we have shown for the ¢rst time that two of
the Tat proteins, namely TatA and TatB, interact within the
same complex. This was shown through di¡erent lines of evi-
dence. Firstly, TatB appears to be unstable in cells lacking
TatA. Secondly, TatA and TatB can be co-immunoprecipi-
tated by antibodies to either protein. Thirdly, TatA and
TatB co-elute from a gel ¢ltration column in a complex of
approximately 600 kDa. It is not yet clear whether the inter-
action of TatA and TatB is direct, or mediated via another
protein (an obvious candidate being TatC). Interestingly, it
has recently been shown that TatB stabilises TatC [11], sug-
gesting that TatC is also present in the TatA^TatB complex.
However, the lack of antibodies recognising TatC at wild-type
levels prevented us thus far from demonstrating the presence
of TatC in this complex. The TatE protein seems not to be of
major importance, as a tatE mutant strain shows only mild
defects in the translocation of Tat substrates [4]. However,
TatA and TatE were shown to be functionally interchangeable
[11].
Interestingly, the results obtained indicate that TatA could
be present in a complex even in the absence of TatB, as: (i)
TatA levels seem to be signi¢cantly higher than those of
TatB; (ii) the stability of TatA was not a¡ected in strains
lacking TatB; (iii) only a minor fraction of TatA could be
immunoprecipitated using anti-TatB antibodies; and (iv)
chromatographic analysis indicated that a portion of TatA
may elute without TatB. Thus, it is conceivable that there is
a heterogeneous population of Tat complexes which vary in
their subunit composition. As TatB is required for the trans-
location of Tat substrates [3,11], complexes lacking TatB
might be in an inactive state.
A major challenge for the future is to establish which other
subunits are present in the Tat complex, and to determine the
stoichiometry of these. Candidates are obviously the TatC
and TatE proteins, but it is also conceivable that other, still
unknown, components are required.
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